News from rxi pharmaceuticals corporation

Jul 07, 2014, 07:02 ET

RXi Pharmaceuticals Appoints Peter Campochiaro M.D. to its Scientific Advisory Board

 RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering, developing and commercializing innovative...

Jul 02, 2014, 07:02 ET
RXi Pharmaceuticals.  (PRNewsFoto/RXi Pharmaceuticals Corporation)

RXi Pharmaceuticals Celebrates Expansion of its Operations in Massachusetts

 RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering, developing and commercializing innovative...

Jun 25, 2014, 07:02 ET
RXi Pharmaceuticals.  (PRNewsFoto/RXi Pharmaceuticals Corporation)

RXi Pharmaceuticals Set to Join Russell Microcap Index

 RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering, developing and commercializing innovative...

May 27, 2014, 07:02 ET
RXi Pharmaceuticals.  (PRNewsFoto/RXi Pharmaceuticals Corporation)

RXi Pharmaceuticals to Present at the Jefferies 2014 Global Healthcare Conference

 RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering, developing and commercializing innovative...

May 22, 2014, 07:02 ET
RXi Pharmaceuticals.  (PRNewsFoto/RXi Pharmaceuticals Corporation)

RXi Pharmaceuticals Granted US Notice of Allowance Covering Self-Delivering (sd-rxRNA) Technology Platform

RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering, developing and commercializing innovative...

May 14, 2014, 07:15 ET
RXi Pharmaceuticals.  (PRNewsFoto/RXi Pharmaceuticals Corporation)

RXi Pharmaceuticals Reports Financial Results for the First Quarter of 2014

RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering, developing and commercializing innovative therapies...

May 02, 2014, 07:02 ET
RXi Pharmaceuticals.  (PRNewsFoto/RXi Pharmaceuticals Corporation)

RXi Pharmaceuticals Announces Positive Results with RXI?109 in the Eyes of Cynomolgus Monkeys as Part of a Dose Range Finding Study

 RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering, developing and commercializing innovative...

Apr 29, 2014, 13:03 ET
RXi Pharmaceuticals.  (PRNewsFoto/RXi Pharmaceuticals Corporation)

RXi Pharmaceuticals Announces Initiation of Phase 2a Keloid Study

RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering, developing and commercializing innovative therapies...

Apr 28, 2014, 07:02 ET
RXi Pharmaceuticals.  (PRNewsFoto/RXi Pharmaceuticals Corporation)

RXi Pharmaceuticals to Present at ARVO 2014 Annual Meeting

 RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering, developing and commercializing innovative...

Apr 22, 2014, 15:29 ET
RXi Pharmaceuticals.  (PRNewsFoto/RXi Pharmaceuticals Corporation)

RXi Pharmaceuticals Enters into Financing Facility with Lincoln Park Capital

 RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering and developing innovative therapies addressing...

Mar 28, 2014, 16:45 ET
RXi Pharmaceuticals.  (PRNewsFoto/RXi Pharmaceuticals Corporation)

RXi Pharmaceuticals Reports Full Year 2013 Financial Results

 RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering, developing and commercializing innovative...

Mar 14, 2014, 07:02 ET
RXi Pharmaceuticals.  (PRNewsFoto/RXi Pharmaceuticals Corporation)

RXi Pharmaceuticals Announces Upcoming Presentations

 RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering, developing and commercializing innovative...

Mar 05, 2014, 07:02 ET
RXi Pharmaceuticals.  (PRNewsFoto/RXi Pharmaceuticals Corporation)

RXi Pharmaceuticals Granted Key Patent Related to Self-Delivering Technology for the Treatment of Fibrotic Disorders

 RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering, developing and commercializing innovative...

Mar 04, 2014, 07:02 ET
RXi Pharmaceuticals.  (PRNewsFoto/RXi Pharmaceuticals Corporation)

RXi Pharmaceuticals to Present at the 26th Annual ROTH Conference

  RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering, developing and commercializing innovative...

Feb 24, 2014, 07:02 ET
RXi Pharmaceuticals.  (PRNewsFoto/RXi Pharmaceuticals Corporation)

RXi Pharmaceuticals to Present at the 24th Annual Wall Street Analyst Forum

 RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering, developing and commercializing innovative...

Feb 11, 2014, 07:02 ET
RXi Pharmaceuticals.  (PRNewsFoto/RXi Pharmaceuticals Corporation)

RXi Pharmaceuticals Announces Listing on NASDAQ Capital Market

 RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering, developing and commercializing innovative...

Feb 03, 2014, 07:02 ET
RXi Pharmaceuticals.  (PRNewsFoto/RXi Pharmaceuticals Corporation)

RXi Pharmaceuticals to Present at the 16th Annual BIO CEO & Investor Conference

  RXi Pharmaceuticals Corporation (OTCQX: RXII), a biotechnology company focused on discovering, developing and commercializing innovative...

Jan 14, 2014, 07:02 ET

RXi Pharmaceuticals Receives US Notice of Allowance for a Key Patent Relating to its Self-Delivering Technology with sd-rxRNAs targeting CTGF, including RXI-109, for the Treatment of Fibrotic Disorders

 RXi Pharmaceuticals Corporation (OTCQX: RXII), a biotechnology company focused on discovering, developing and commercializing innovative...

Jan 06, 2014, 07:02 ET
RXi Pharmaceuticals.  (PRNewsFoto/RXi Pharmaceuticals Corporation)

RXi Pharmaceuticals to Present at the Biotech Showcase™ 2014

 RXi Pharmaceuticals Corporation (OTCQX: RXII), a biotechnology company focused on discovering, developing and commercializing innovative...

Dec 04, 2013, 08:05 ET
RXi Pharmaceuticals.  (PRNewsFoto/RXi Pharmaceuticals Corporation)

RXi Pharmaceuticals Announces mRNA Data of an Additional Cohort in the Second Phase 1 Multi-Dose Study with RXI-109, Extending the Dose Response Following Treatment in the Initial 2-week Period

 RXi Pharmaceuticals Corporation (OTCQX: RXII), a biotechnology company focused on discovering, developing and commercializing innovative...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

ReportBuyer
Research and Markets
Investor-Edge